电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CEP55 抗体

This anti-CEP55 antibody is a 兔 多克隆 antibody detecting CEP55 in WB 和 IF. Suitable for 人, 大鼠 和 小鼠.
产品编号 ABIN7264273
发货至: 中国

Quick Overview for CEP55 抗体 (ABIN7264273)

抗原

See all CEP55 抗体
CEP55 (Centrosomal Protein 55kDa (CEP55))

适用

  • 38
  • 7
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
人, 大鼠, 小鼠

宿主

  • 37
  • 3

克隆类型

  • 39
  • 1
多克隆

标记

  • 28
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CEP55 antibody is un-conjugated

应用范围

  • 31
  • 19
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF)
  • 产品特性

    Polyclonal Antibody

    纯化方法

    Affinity purification

    免疫原

    Recombinant fusion protein of human CEP55 (NP_060601.3).

    亚型

    IgG
  • 应用备注

    WB 1:500-1:2000 IF 1:50-1:200

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store at -20°C. Avoid freeze / thaw cycles.
  • 抗原

    CEP55 (Centrosomal Protein 55kDa (CEP55))

    别名

    CEP55

    背景

    Centrosomal protein of 55 kDais aproteinthat in humans is encoded by theCEP55gene. CEP55 is a mitotic phosphoprotein that plays a key role in cytokinesis, the final stage of cell division. Interacts (phosphorylated on Ser-425 and Ser-428) with PLK1. Interacts with AKAP9, the interaction occurs in interphase and is lost upon mitotic entry. Interacts with PCNT, the interaction occurs in interphase and is lost upon mitotic entry. Interacts with PDCD6IP, the interaction is direct, CEP55 binds PDCD6IP in a 2:1 stoechiometry, PDCD6IP competes with TSG101 for the same binding site.

    分子量

    Observed_MW: 60 kDa

    Calculated_MW: 46 kDa/54 kDa

    基因ID

    55165

    UniProt

    Q53EZ4
You are here:
Chat with us!